Fumiyuki Isami
- Complementary and alternative medicine top 2%
- Toxicology top 2%
- Pharmacology top 10%
- Biochemistry top 10%
- Molecular Biology
- Co-authors
- Akemi UwayaBrett J. WestShixin DengC. Jarakae JensenKazuya MurataHideaki MatsudaSho‐ichi YamagishiSanae Nakajima
- Topics
- Morinda citrifolia extract uses (14 papers)Bioactive Compounds and Antitumor Agents (9 papers)Pharmacological Effects of Natural Compounds (6 papers)
- Journals
- SHILAP Revista de lepidopterologíaPhysiology & BehaviorCurrent Pharmaceutical Design
- Partner nations
- Japan
In The Last Decade
Fumiyuki Isami
22 papers receiving 354 citations
Peers
Comparison fields: 5 of 85
- Complementary and alternative medicine 175
- Toxicology 82
- Pharmacology 72
- Biochemistry 67
- Molecular Biology 54
Countries citing papers authored by Fumiyuki Isami
This map shows the geographic impact of Fumiyuki Isami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiyuki Isami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiyuki Isami more than expected).
Fields of papers citing papers by Fumiyuki Isami
This network shows the impact of papers produced by Fumiyuki Isami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiyuki Isami. The network helps show where Fumiyuki Isami may publish in the future.
Co-authorship network of co-authors of Fumiyuki Isami
This figure shows the co-authorship network connecting the top 25 collaborators of Fumiyuki Isami. A scholar is included among the top collaborators of Fumiyuki Isami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiyuki Isami. Fumiyuki Isami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 6 | |
| 3 | 8 | |
| 4 | 20 | |
| 5 | 9 | |
| 6 | 39 | |
| 7 | 55 | |
| 8 | 15 | |
| 9 | Inhibition of AGE-induced Melanogenesis in B16 Melanoma Cells by Iridoid-containing Plants | 2 |
| 10 | 21 | |
| 11 | Melanin synthesis induction by advanced glycation end-products (AGEs) without .ALPHA.-melanocyte stimulating hormone (.ALPHA.-MSH) or UV exposure | 1 |
| 12 | 20 | |
| 13 | 9 | |
| 14 | 16 | |
| 15 | 19 | |
| 16 | 26 | |
| 17 | 12 | |
| 18 | 4 | |
| 19 | 31 | |
| 20 | 49 |
About Fumiyuki Isami
Fumiyuki Isami is a scholar working on Toxicology, Complementary and alternative medicine and Biochemistry, having authored 23 papers that have together received 402 indexed citations. Recurring topics across this work include Morinda citrifolia extract uses (14 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Pharmacological Effects of Natural Compounds (6 papers). The work is most often cited by research in Toxicology (82 citations), Complementary and alternative medicine (175 citations) and Biochemistry (67 citations). Fumiyuki Isami has collaborated with scholars based in Japan. Frequent co-authors include Akemi Uwaya, Brett J. West, Shixin Deng, C. Jarakae Jensen, Kazuya Murata, Hideaki Matsuda, Sho‐ichi Yamagishi, Sanae Nakajima, Shunsuke Naruto and Megumi Masuda. Their work appears in journals such as SHILAP Revista de lepidopterología, Physiology & Behavior and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.